![Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus erythematosus - ScienceDirect Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus erythematosus - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S258990902100037X-gr2.jpg)
Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus erythematosus - ScienceDirect
![A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus | Nature Communications A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-26912-6/MediaObjects/41467_2021_26912_Fig1_HTML.png)
A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus | Nature Communications
Early Virological and Immunological Events in Asymptomatic Epstein-Barr Virus Infection in African Children | PLOS Pathogens
![Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands | SpringerLink Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11481-020-09948-1/MediaObjects/11481_2020_9948_Figa_HTML.png)
Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands | SpringerLink
![Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections | Clinical Microbiology Reviews Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections | Clinical Microbiology Reviews](https://journals.asm.org/cms/10.1128/CMR.00044-10/asset/cc13d41f-0a67-42c6-b353-bcc2d249468e/assets/graphic/zcm9990923420002.jpeg)
Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections | Clinical Microbiology Reviews
![Anti-Epstein–Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel - KL Munger, LI Levin, EJ O'Reilly, KI Falk, A Ascherio, 2011 Anti-Epstein–Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel - KL Munger, LI Levin, EJ O'Reilly, KI Falk, A Ascherio, 2011](https://journals.sagepub.com/cms/10.1177/1352458511408991/asset/images/large/10.1177_1352458511408991-fig2.jpeg)
Anti-Epstein–Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel - KL Munger, LI Levin, EJ O'Reilly, KI Falk, A Ascherio, 2011
![Frontiers | Epstein-Barr Virus and multiple sclerosis in a Spanish cohort: A two-years longitudinal study Frontiers | Epstein-Barr Virus and multiple sclerosis in a Spanish cohort: A two-years longitudinal study](https://www.frontiersin.org/files/Articles/991662/fimmu-13-991662-HTML/image_m/fimmu-13-991662-g001.jpg)
Frontiers | Epstein-Barr Virus and multiple sclerosis in a Spanish cohort: A two-years longitudinal study
![Anti-Epstein–Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel - KL Munger, LI Levin, EJ O'Reilly, KI Falk, A Ascherio, 2011 Anti-Epstein–Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel - KL Munger, LI Levin, EJ O'Reilly, KI Falk, A Ascherio, 2011](https://journals.sagepub.com/cms/10.1177/1352458511408991/asset/images/large/10.1177_1352458511408991-fig1.jpeg)
Anti-Epstein–Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel - KL Munger, LI Levin, EJ O'Reilly, KI Falk, A Ascherio, 2011
![Identification of Potential Inhibitors against Epstein–Barr Virus Nuclear Antigen 1 (EBNA1): An Insight from Docking and Molecular Dynamic Simulations | ACS Chemical Neuroscience Identification of Potential Inhibitors against Epstein–Barr Virus Nuclear Antigen 1 (EBNA1): An Insight from Docking and Molecular Dynamic Simulations | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/acschemneuro.1c00350/asset/images/large/cn1c00350_0006.jpeg)
Identification of Potential Inhibitors against Epstein–Barr Virus Nuclear Antigen 1 (EBNA1): An Insight from Docking and Molecular Dynamic Simulations | ACS Chemical Neuroscience
![Epidemiological risk factors associated with primary infection by Epstein–Barr virus in HIV-1-positive subjects in the Brazilian Amazon region | Scientific Reports Epidemiological risk factors associated with primary infection by Epstein–Barr virus in HIV-1-positive subjects in the Brazilian Amazon region | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-97707-4/MediaObjects/41598_2021_97707_Fig1_HTML.png)
Epidemiological risk factors associated with primary infection by Epstein–Barr virus in HIV-1-positive subjects in the Brazilian Amazon region | Scientific Reports
![Vaccines | Free Full-Text | An Absence of Epstein–Barr Virus Reactivation and Associations with Disease Activity in People with Multiple Sclerosis Undergoing Therapeutic Hookworm Vaccination | HTML Vaccines | Free Full-Text | An Absence of Epstein–Barr Virus Reactivation and Associations with Disease Activity in People with Multiple Sclerosis Undergoing Therapeutic Hookworm Vaccination | HTML](https://www.mdpi.com/vaccines/vaccines-08-00487/article_deploy/html/images/vaccines-08-00487-g001.png)